Skip to main content

Geneseek, NALF Partner on Genetic Testing of Limousin Cattle

NEW YORK (GenomeWeb News) – The North American Limousin Foundation announced on Tuesday a non-exclusive deal with Geneseek covering genomic testing services.

In addition to the provision of testing services, the deal also includes a NALF exclusive product combining a test from NALF to be run on Geneseek's technology. The new Igenity-Enabled Limousin Genetic Profiler runs on the Geneseek Genomic Profiler, a low density bead chip, and yields molecular breeding values that will be used in NALF's National Cattle Evaluation starting in the fall.

Financial and other terms of the deal were not disclosed.

Mark Anderson, executive director of NALF, said in a statement that the new test "offers additional information and promise of enhanced [expected progeny differences] accuracy for our breeders."

Geneseek, a Neogen company, will also do testing for myostatin and other genetic defects for NALF, the foundation said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.